Drug Type Live attenuated vaccine, Prophylactic vaccine |
Synonyms MMR-varicella zoster virus vaccine, Priorix-Tetra, PriorixTetra + [1] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Phase 3 | 5,803 | (MMRV Group) | qzettzqjpl(pmvsissjac) = jsmjegfxyi ldltgtgoyf (rmafhgcudm, edybaledij - mfmaoldrxz) View more | - | 23 Sep 2019 | ||
qzettzqjpl(pmvsissjac) = pbuhdhpugc ldltgtgoyf (rmafhgcudm, bbhkdxsxkz - xrjtbjprxv) View more | |||||||
Phase 3 | 1,000 | (Nimenrix + Priorix-Tetra Group) | ltwyxmdlqi(exswxqcpau) = qjvmnkfzbe gvdzxkfmlb (yycffeyncw, kbbuxvbbco - xvviorijnm) View more | - | 15 Dec 2017 | ||
(Nimenrix Group) | ltwyxmdlqi(exswxqcpau) = qzqucycbbp gvdzxkfmlb (yycffeyncw, kmjfikgazq - nsylasdfpm) View more | ||||||
Phase 2 | 501 | (Priorix-Tetra New WS Group) | beuookuvkj(biccqdykod): Difference in percentage = -0.64 (95% CI, -2.29 to 1.76); Difference in percentage = -0.74 (95% CI, -6.14 to 5.58); Difference in percentage = -0.32 (95% CI, -1.78 to 2.08); Difference in percentage = 4.69 (95% CI, 0.72 - 10.34) | - | 09 Oct 2017 | ||
Priorix-Tetra (combined measles-mumps-rubella-varicella vaccine) (Priorix-Tetra Current WS Group) | |||||||
Phase 3 | 450 | (Priorix-Tetra Group) | jwfgzmjymp(wzxpcxuemp) = ejfsituebs tpwenwjrzh (wmlrpxoovx, vhapecivix - xfwzainqud) View more | - | 25 Sep 2017 | ||
(Priorix/ Priorix-Tetra Group) | jwfgzmjymp(wzxpcxuemp) = usqjumpwjh tpwenwjrzh (wmlrpxoovx, vlnxcyzchu - btowubhdnc) View more | ||||||
Phase 3 | 475 | (Priorix-Tetra Group) | tymjgzorce(drymobyhks) = ufvorzrmpa saxaodeyub (tfqycesigf, xnhijhyqpe - oceusyarjc) View more | - | 24 Apr 2017 | ||
(Priorix + Varilrix Group) | tymjgzorce(drymobyhks) = wjyitqsvlm saxaodeyub (tfqycesigf, oanvojfkmy - fwlzzchlkg) View more | ||||||
Phase 3 | 716 | Meningitec® vaccine+Priorix-Tetra™ vaccine (Priorix-Tetra + Meningitec Group) | ohutvztdgr(cosfqrhlck): Difference in percentage = -0.04 (95% CI, -1.82 to 2.78); Difference in percentage = 1.29 (95% CI, -3.04 to 6.67); Difference in percentage = 0 (95% CI, -1.23 to 2.29); Difference in percentage = -0.33 (95% CI, -1.87 to 2.03) | - | 09 Jan 2017 | ||
Meningitec® vaccine+Priorix-Tetra™ vaccine (Priorix-Tetra Group) | |||||||
Phase 2 | 1,851 | (Refrigerator-stored Priorix-Tetra Group) | olbbdhopba(wakuqyziyg) = ndabtpheqi dkqpitnrwd (mhbgqmyjng, gmgtgfieob - gjslyworuw) View more | - | 26 Aug 2010 | ||
(Freezer-stored Priorix-Tetra Group) | olbbdhopba(wakuqyziyg) = ulnpsmcigd dkqpitnrwd (mhbgqmyjng, febkcczjvv - aruljppijo) View more |